Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Hikma Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Hikma Pharmaceuticals şirketinin toplam hissedar öz sermayesi $2.3B ve toplam borcu $1.2B olup, bu da borç-öz sermaye oranını 53.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $4.8B ve $2.5B dir. Hikma Pharmaceuticals 'in FAVÖK'ü $712.0M faiz karşılama oranı 11 dur. Şirketin $260.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
53.2%
Borç/özkaynak oranı
US$1.22b
Borç
Faiz karşılama oranı | 11x |
Nakit | US$260.00m |
Eşitlik | US$2.30b |
Toplam yükümlülükler | US$2.55b |
Toplam varlıklar | US$4.85b |
Son finansal sağlık güncellemeleri
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Recent updates
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 11Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate
Aug 01Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: HIK 'nin kısa vadeli varlıkları ( $2.3B ) kısa vadeli yükümlülüklerini ( $1.4B ) aşıyor.
Uzun Vadeli Yükümlülükler: HIK şirketinin kısa vadeli varlıkları ( $2.3B ) uzun vadeli yükümlülüklerini ( $1.2B ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: HIK 'nin net borç/öz sermaye oranı ( 41.9% ) yüksek olarak değerlendiriliyor.
Borcun Azaltılması: HIK şirketinin borç/öz sermaye oranı son 5 yılda 34.1% seviyesinden 53.2% seviyesine yükseldi.
Borç Kapsamı: HIK 'nin borcu işletme nakit akışı ( 47.8% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: HIK 'in borcuna ilişkin faiz ödemeleri EBIT ( 11 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.